Contact this trialFirst, we need to learn more about you.
Cannabinoid
CBD for Autism Spectrum Disorder
Recruiting3 awardsPhase 2
New York, New York
This trial is testing cannabidiol (CBD) to see if it's an effective treatment for symptoms associated with autism spectrum disorder (ASD), in children and adolescents. They are using a 98% pure CBD oral solution, given at a dose of 9 mg/kg/day. They will be testing up to 15 additional participants who also have a diagnosis of attention-deficit/hyperactivity disorder (ADHD).
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.